What is the Fiscal Year for Ascentage Pharma?
Date: November 14, 2026
Ascentage Pharma's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Suzhou, Jiangsu, China
Industry
Biotechnology Research
Stock Symbol
AAPGV
Website
https://ascentagepharma.comDescription
Ascentage Pharma is a global, integrated biopharmaceutical company engaged in discovering, developing and commercializing therapies to address global unmet medical needs primarily in hematological malignancies and is in the process of conducting more than 40 clinical trials in specific regions worldwide. Ascentage Pharma has been listed on the Main Board of the HKEX with the stock code 6855.HK since October 2019 and recently listed in NASDAQ in January 2025 under the stock code AAPG.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like Ascentage Pharma and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.